IFN-α leads to decreased mRNA levels of the immunosuppressive cytokine IL-10 in BCCs. Treatment with IFN-α led to increased proportion of CD3+ cells within peri- and intratumoral infiltrates of BCCs as well as an increase in the CD4/CD8 ratio in both peri- and intratumoral infiltrates.